Buchumschlag

Multidrug-resistant bacteria and disease progression in patients with end-stage liver disease and after liver transplantation

Background: Multidrug-resistant (MDR) pathogens represent an emerging challenge in end-stage liver disease and in liver transplant recipients. - Methods: We evaluated the impact of MDR bacteria upon clinical outcomes in patients with end-stage liver disease (n = 777) at the time of enrollment on the...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Friedrich, Kilian (VerfasserIn) , Schamoni, Shigehiko (VerfasserIn) , Wenz, Theresa (VerfasserIn) , Pfeiffenberger, Jan (VerfasserIn) , Rupp, Christian (VerfasserIn) , Gotthardt, Daniel (VerfasserIn) , Houben, Philipp (VerfasserIn) , Haken, Rebecca von (VerfasserIn) , Heininger, Alexandra (VerfasserIn) , Brenner, Thorsten (VerfasserIn) , Mehrabi, Arianeb (VerfasserIn) , Weiss, Karl Heinz (VerfasserIn) , Mieth, Markus (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 13 July 2019
In: Journal of gastrointestinal and liver diseases
Year: 2019, Jahrgang: 28, Heft: 3, Pages: 303-310
ISSN:1842-1121
DOI:10.15403/jgld-212
Online-Zugang:Verlag, Volltext: https://doi.org/10.15403/jgld-212
Verlag: https://www.jgld.ro/jgld/index.php/jgld/article/view/212
Volltext
Verfasserangaben:Kilian Friedrich, Jessica Krempl, Shigehiko Schamoni, Theresa Hippchen, Jan Pfeiffenberger, Christian Rupp, Daniel Nils Gotthardt, Philip Houben, Rebecca von Haken, Alexandra Heininger, Thorsten Brenner, Arianeb Mehrabi, Karl-Heinz Weiss, Markus Mieth
Beschreibung
Zusammenfassung:Background: Multidrug-resistant (MDR) pathogens represent an emerging challenge in end-stage liver disease and in liver transplant recipients. - Methods: We evaluated the impact of MDR bacteria upon clinical outcomes in patients with end-stage liver disease (n = 777) at the time of enrollment on the liver transplant (LTx) waiting list, after first LTx (n = 645), and after second LTx (n = 128). - Results: Colonization/infection with MDR bacteria was present in 72/777 patients on the waiting list, in 98/645 patients at first LTx, and in 46/128 patients at second LTx. While on the LTx waiting list, the time until first hydropic decompensation (p = 0.021), hepatic encephalopathy (p < 0.001) and hepatorenal syndrome (p < 0.001) was reduced in the presence of MDR bacteria, which remained an independent risk factor of poor survival in multivariate analysis (p < 0.001). Following first and second liver transplant, MDR bacteria were associated with an increased risk of infection-related deaths (first LTx: p < 0.001; second LTx: p = 0.037) and reduced actuarial survival (first LTx: p < 0.001; second LTx: p = 0.046). - Conclusions: We showed that MDR pathogens are associated with poor outcomes before, after first and after recurrent LTx.
Beschreibung:Gesehen am 04.11.2019
Beschreibung:Online Resource
ISSN:1842-1121
DOI:10.15403/jgld-212

Ähnliche Einträge